Who and when should we screen for prostate cancer? Interviews with key opinion leaders Article uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine's 'Spotlight on Prostate Cancer' article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world's key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts' views and give their own personal opinions on PSA screening.

publication date

  • November 27, 2015

Research

keywords

  • Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4662021

Digital Object Identifier (DOI)

  • 10.1186/s12916-015-0526-x

PubMed ID

  • 26612204

Additional Document Info

start page

  • 288

volume

  • 13

number

  • 1